CanSinoBIO gets China nod for inhaled COVID-19 vaccine trial
China’s CanSino Biologics Inc (CanSinoBIO) said on Tuesday it won approval for a clinical trial in the country to develop a COVID-19 vaccine for inhalation.
The National Medical Products Administration approved the trial of the vaccine, jointly developed by CanSinoBIO and the Beijing Institute of Biotechnology, the company said.
The company’s COVID-19 vaccine for injection was recently approved for emergency use in Hungary.
- Latest coronavirus numbers: Hungary records highest ever daily COVID death toll
- Hungary’s medicines authority: Strict regulations must be met for new vaccines from India and China
Read alsoHungary approves Indian CoviShield and China’s CanSino vaccine for emergency use – UPDATE
If you would like to support the work of the Daily News Hungary staff and independent journalism,
please make a donation here
please make a donation here
Hot news
Is your luck running out? These Hungarian superstitions could change everything!
UEFA Nations League: Hungary levels the score against Germany in 99th minute, Szalai receives thoughtful gift – PHOTOS
Hungarian Defence Minister: Diplomacy ‘only solution’ to end war
Top Hungary news: Serbia partners with Paks, Christmas market prices, prison for commenting, traffic changes, HUF 50,000 coin – 19 November, 2024
Orbán cabinet: Relations between Hungary and the UK to further strengthen
Hungarian Foreign Minister Szijjártó: More people in Europe becoming reasonable about illegal migration
